We are pleased to share with you the Meet the Expert Sessions for the upcoming BSH 2021 Virtual ASM. The Meet the Expert Sessions are an opportunity for you to hear from leading figures in the field of haematology in a less formal setting. The 45 minute sessions are limited to 50 people per session to maintain the intimate nature of the sessions, allowing you to engage with the experts and ask live questions in the session.
Please also note there are a number of Meet the expert session run by our Industry partners.
Registering for the sessions
The sessions will become available in the platform 24 Hours before the session is due to start, to book on the session you will need to login to the platform and add to your schedule. By adding to your schedule this is confirmation of you booking the session. As the places are limited we kindly ask that if you add this to your schedule please remember to attend or remove from your schedule if you know you are unable to attend as this will open it up for others to attend.
Please see below the list of Meet the Expert Sessions taking place over the 4 day programme. Start planning your days in advance. Sessions are presented live in the programme and will not be made available on demand.
| Time |
Session 1 |
Session 2 |
Session 3 |
Session 4 |
| 12:15 - 13:00 |
Hypoplastic MDS and its overlap with other bone marrow failures'
Austin Kulasekaraj & Henry Wood |
Update on AL amyloidosis
Ashutosh Wechalekar & Guy Pratt |
Management of MPN
Claire Harrison & Donal McLornan |
|
| 18:00 - 18:45 |
Industry Partner Session Novartis |
Industry Partner Session Novartis |
Transfusion and Haemoglobinopathies (sickle cell disease and thalassaemia)
Sara Trompeter & Rosanna Ghinai |
Intravital imaging of NETs, platelets and coagulation
Craig Jenne & Carsten Deppermann |
| Time |
Session 1 |
Session 2 |
Session 3 |
Session 4 |
| 07:30 - 08:15 |
Industry Partner Session MEDAC |
CD19 CAR T Therapy or DLBCL; who, when and how?
Andrea Kuhnl & Claire Roddie |
Perioperative management of DOACs for scheduled surgery and urgent procedures
Marc Samama |
|
| 12:00 - 12:45 |
|
Industry Partner Session Janssen |
Meet the BSH: A Society Built by its Members
Adele Fielding, Josh Wright, Mai Khalifa and Edwin Massey |
How GPs manage the fear of "missing" something
Lesley Perkins & Osman Bhatti |
| 18:30 - 19:15 |
|
Treatment of AML patients older than 60 - ven/aza or not
Mike Dennis & Emma Searle |
What's the modern approach to ITP management/how do we manage ITP in the modern era?
Drew Provan & Julia Czuprynska |
|
| Time |
Session 1 |
Session 2 |
Session 3 |
Session 4 |
Session 5 |
| 08:00 - 08:45 |
AI and Epidemiology of VTE and AF
Alexander Cohen & Miroslaw Bober |
Treatment of myelofibrosis
Adam Mead |
|
|
|
| 12:15 - 13:00 |
Industry Partner Session Beigene |
Industry Partner Session Janssen
Please note: This session now runs from 12:00 - 12:45. |
Haemostatic management of intracerebral haemorrhage
Michael Desborough |
Genomic testing: managing consent, incidental findings and variants of uncertain significance
Keith Gomez & Kate Downes |
What's new in patient blood management?
Suzy Morton & Andy Charlton |
| 18:15 - 19:00 |
Industry Partner Session AstraZeneca
George Follows, Anna Schuh, Sunil Lyengar & Orla Stewart |
Selecting and sequencing novel therapies for CLL in 2021
Talha Munir & Sreetharan Munisamy |
Thrombosis - what's new?
William Lester & Pip Nicolson |
COVID, immune dysfunction and vaccination
Alex Richter & Benard Maybury |
|
| Time |
Session 1 |
Session 2 |
Session 3 |
Session 4 |
| 07:30 - 08:15 |
Sequencing of myeloma therapy in 2021
Graham Jackson & Alex Langridge |
How to support your doctors, nurses and other practitioners
Sarah Whitaker & Laura Flower |
Molecular Biomarkers in Lymphoma
Cathy Burton & Dan Hodson |
|
| 12:00 - 12:45 |
Industry Partner Session Novartis |
Industry Partner Session AbbVie |
In utero treatment of haemoglobinopathy - can this be the future of stem cell therapies in sickle cell disease and thalassaemia?
Panicos Shangaris & Stavros Loukogeorgakis |
When should patients with Haematological malignancies meet Palliative care teams?
Jane Neerkin, Caroline Stirling, Katy Burke, Caroline Williams, Emily Anderson, Dr Sara Delgado and Jo Bennetts |
